Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
In a recent interview, Ioannis Sechopoulos, Ph.D, and Sarah D. Verboom, MSc discussed their new research examining the role of certainty in AI mammography screening assessment and the potential impact on workload reduction for radiologists.
Could A Specificity Emphasis for MRI-Based T-Staging Reinvent Staging for Prostate Cancer?
In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.
In the second part of a recent interview, Tammie Benzinger, M.D., Ph.D., discusses recently presented research from the Alzheimer’s Association International Conference (AAIC) that showed the ability of portable low-field MRI to detect mild and moderate amyloid-related imaging abnormalities (ARIAs).
FDA Clears AI-Guided Point-of-Care Ultrasound for Liver Diseases
Reportedly the only point-of-care ultrasound system that can estimate liver stiffness and attenuation that correlate to MRI-PDFF, Velacur One also may facilitate higher reimbursement than non-imaging elastography.
Emerging Trends with Burnout in Radiology: An Interview with Chris Mattern, MD, Part 2
In the second part of a recent interview, Chris Mattern. M.D., discussed the increasing burden of non-clinical tasks upon radiologist workloads and the potential of the emerging enterprise imaging platform MosaicOS to address efficiency and restore the focus on clinical care.
The Reading Room Podcast: Emerging Trends with Theranostics in Prostate Cancer, Part 2
In the second of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss current and emerging alpha-emitting therapies, possible roles for artificial intelligence (AI), and what the future may hold for theranostic applications in patients with prostate cancer.
PSMA PET/CT Facilitates Better Long-Term Survival Rates After Salvage Radiotherapy for Recurrent PCa
Patient with biochemical recurrence of prostate cancer who had PSMA PET/CT prior to salvage radiotherapy had better survival rates at one, two and five years, according to newly published research.
Digital Breast Tomosynthesis Study Assesses Impact of Architectural Distortion on Malignancy Rates
Researchers noted a 78 percent malignancy rate when associated architectural distortion was present on digital breast tomosynthesis (DBT) with highly suspicious masses or microcalcifications.
In a recent interview, Tammie Benzinger, M.D., Ph.D., discussed the utility of portable low-field MRI to help identify patients in remote settings who may be viable candidates for subsequent MRI workup and consideration for new anti-amyloid therapies in treating Alzheimer’s disease.
Study Suggests Benefits of FDG PET/CT for Detecting Oligometastatic Breast Cancer
In comparison to computed tomography and bone scintigraphy, FDG PET/CT detected more oligometastatic and polymetastatic disease in patients with locally advanced breast cancer, according to a new study.
Can Multimodal AI Enhance Prediction of Biochemical Recurrence After Prostatectomy?
A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.